Alvotech And Teva : FDA Approves Selarsdi Injection For Psoriasis And Psoriatic Arthritis
17/4 05:10
(RTTNews) - The U.S. Food and Drug Administration has approved Selarsdi (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara, for the treatment of moderate to severe plaque psoriasis and for active psoriatic arthritis in adults and pediatric patients 6 ye...